Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
JNJ Johnson & Johnson	$257.82 +0.3%	$237.62	$154.80 ▼ $269.43	$618.61B	0.24	8.26 million shs	5.24 million shs
NVAX Novavax	$8.91 -4.5%	$9.39	$6.20 ▼ $11.97	$1.53B	2.43	4.09 million shs	3.85 million shs
PFE Pfizer	$24.46 +1.2%	$25.32	$23.11 ▼ $28.75	$137.76B	0.35	47.17 million shs	42.73 million shs

7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
JNJ Johnson & Johnson	+0.25%	-0.57%	+7.17%	+7.36%	+64.35%
NVAX Novavax	-4.50%	-4.71%	+0.34%	+6.20%	+30.26%
PFE Pfizer	+1.02%	+3.04%	-6.60%	-9.84%	-4.64%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
JNJ Johnson & Johnson	$257.82 +0.3%	$237.62	$154.80 ▼ $269.43	$618.61B	0.24	8.26 million shs	5.24 million shs
NVAX Novavax	$8.91 -4.5%	$9.39	$6.20 ▼ $11.97	$1.53B	2.43	4.09 million shs	3.85 million shs
PFE Pfizer	$24.46 +1.2%	$25.32	$23.11 ▼ $28.75	$137.76B	0.35	47.17 million shs	42.73 million shs

7 Best Space Stocks to Own in 2026

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
JNJ Johnson & Johnson	+0.25%	-0.57%	+7.17%	+7.36%	+64.35%
NVAX Novavax	-4.50%	-4.71%	+0.34%	+6.20%	+30.26%
PFE Pfizer	+1.02%	+3.04%	-6.60%	-9.84%	-4.64%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
JNJ Johnson & Johnson	2.74	Moderate Buy	$261.26	1.33% Upside
NVAX Novavax	2.40	Hold	$13.00	45.90% Upside
PFE Pfizer	2.19	Hold	$28.50	16.51% Upside

Current Analyst Ratings Breakdown

Latest PFE, NVAX, and JNJ Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/13/2026	JNJ Johnson & Johnson	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$250.00 ➝ $300.00
7/13/2026	JNJ Johnson & Johnson	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Outperform	$265.00 ➝ $287.00
7/13/2026	PFE Pfizer	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Outperform	$34.00 ➝ $30.00
7/13/2026	PFE Pfizer	Guggenheim Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$36.00 ➝ $35.00
7/10/2026	JNJ Johnson & Johnson	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$254.00 ➝ $263.00
7/10/2026	PFE Pfizer	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$27.00 ➝ $26.00
7/8/2026	JNJ Johnson & Johnson	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$283.00 ➝ $284.00
7/8/2026	JNJ Johnson & Johnson	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$285.00 ➝ $298.00
7/8/2026	PFE Pfizer	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Neutral	$30.00 ➝ $28.00
7/6/2026	JNJ Johnson & Johnson	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target	Buy	$290.00
7/6/2026	PFE Pfizer	HSBC Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Buy ➝ Hold	$32.00 ➝ $28.00

(Data available from 7/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
JNJ Johnson & Johnson	$94.19B	6.59	$14.17 per share	18.20	$33.85 per share	7.62
NVAX Novavax	$1.12B	1.30	$3.35 per share	2.66	($0.79) per share	-11.28
PFE Pfizer	$62.58B	2.23	$4.45 per share	5.50	$15.26 per share	1.60

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
JNJ Johnson & Johnson	$26.80B	$8.65	29.81	20.41	2.51	21.83%	32.60%	13.29%	7/15/2026 (Estimated)
NVAX Novavax	$440.30M	-$0.58	N/A	N/A	N/A	-14.73%	-14.82%	1.23%	8/5/2026 (Estimated)
PFE Pfizer	$7.77B	$1.31	18.67	8.55	N/A	11.83%	19.44%	8.41%	8/4/2026 (Estimated)

Latest PFE, NVAX, and JNJ Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/5/2026	Q2 2026	NVAX Novavax	-$0.3961	N/A	N/A	N/A	$52.06 million	N/A
8/4/2026	Q2 2026	PFE Pfizer	$0.68	N/A	N/A	N/A	$14.41 billion	N/A
7/15/2026	Q2 2026	JNJ Johnson & Johnson	$2.85	N/A	N/A	N/A	$25.02 billion	N/A
5/6/2026	Q1 2026	NVAX Novavax	-$0.25	-$0.06	+$0.19	-$0.06	$79.81 million	$118.90 million
5/5/2026	Q1 2026	PFE Pfizer	$0.7220	$0.75	+$0.0280	$0.47	$13.84 billion	$14.45 billion
4/14/2026	Q1 2026	JNJ Johnson & Johnson	$2.68	$2.70	+$0.02	$2.14	$23.60 billion	$24.06 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
JNJ Johnson & Johnson	$5.36	2.08%	+5.25%	61.97%	64 Years
NVAX Novavax	N/A	N/A	N/A	N/A	N/A
PFE Pfizer	$1.72	7.03%	-13.20%	131.30%	16 Years

Latest PFE, NVAX, and JNJ Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/24/2026	PFE Pfizer	quarterly	$0.43	7.15%	7/24/2026	7/24/2026	9/1/2026
4/22/2026	PFE Pfizer	quarterly	$0.43	6.71%	5/8/2026	5/8/2026	6/12/2026
4/14/2026	JNJ Johnson & Johnson	quarterly	$1.34	2.33%	5/26/2026	5/26/2026	6/9/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
JNJ Johnson & Johnson	0.46	1.03	0.77
NVAX Novavax	N/A	2.48	2.45
PFE Pfizer	0.67	1.25	0.94

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
JNJ Johnson & Johnson	69.55%
NVAX Novavax	53.04%
PFE Pfizer	68.36%

Insider Ownership

Company	Insider Ownership
JNJ Johnson & Johnson	0.16%
NVAX Novavax	1.60%
PFE Pfizer	0.62%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
JNJ Johnson & Johnson	138,200	2.41 billion	2.40 billion	Optionable
NVAX Novavax	1,990	164.44 million	161.81 million	Optionable
PFE Pfizer	75,000	5.70 billion	5.66 billion	Optionable

PFE, NVAX, and JNJ Headlines

Recent News About These Companies

Donald Trump's Drug-Pricing Deals Are Reshaping Big Pharma -- Here's What That Means for Pfizer, AbbVie, and Bristol Myers Squibb

1 hour ago | fool.com

Pfizer Inc. $PFE Shares Sold by Calamos Advisors LLC

2 hours ago | marketbeat.com

Can Pfizer (NYSE:PFE) Reinforce Its Value Stock Appeal?

July 13 at 8:32 PM | kalkinemedia.comK

Pfizer (PFE) Advances While Market Declines: Some Information for Investors

July 13 at 8:32 PM | finance.yahoo.com

Pfizer (PFE) Advances While Market Declines: Some Information for Investors

July 13 at 6:45 PM | zacks.com

Pfizer (NYSE:PFE) Stock Price Up 1.2% - What's Next?

July 13 at 5:20 PM | marketbeat.com

Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?

July 13 at 4:50 PM | 247wallst.com

Abbott Labs Vs. Pfizer: Which Discounted Healthcare Titan Screens as the Bigger Value Trap?

July 13 at 4:47 PM | 247wallst.com

2 Value Stocks Worth Your Attention and 1 Facing Headwinds

July 13 at 3:31 PM | finance.yahoo.com

The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions (PFE)

...

July 13 at 12:25 PM | marketbeat.com

How Does LLY Stock Reach $2,100?

July 13 at 10:30 AM | trefis.comT

What It Means To Hold Moderna Stock In A Crash

July 13 at 10:30 AM | trefis.comT

Pfizer (NYSE:PFE) Given New $30.00 Price Target at BMO Capital Markets

July 13 at 9:11 AM | marketbeat.com

Pfizer (NYSE:PFE) Price Target Cut to $35.00 by Analysts at Guggenheim

July 13 at 8:59 AM | marketbeat.com

Triglav Investments D.O.O. Has $8.89 Million Position in Pfizer Inc. $PFE

July 13 at 6:00 AM | marketbeat.com

Pfizer Inc. $PFE Shares Purchased by CORDA Investment Management LLC.

July 13 at 4:07 AM | marketbeat.com

Diversify Wealth Management LLC Has $3.35 Million Position in Pfizer Inc. $PFE

July 13 at 3:59 AM | marketbeat.com

Citizens Financial Group Inc. RI Trims Stock Holdings in Pfizer Inc. $PFE

July 13 at 3:44 AM | marketbeat.com

LGT Fund Management Co Ltd. Buys 765,044 Shares of Pfizer Inc. $PFE

July 12 at 1:44 PM | marketbeat.com

Pfizer Inc. $PFE Shares Sold by International Assets Investment Management LLC

July 12 at 1:44 PM | marketbeat.com

Pfizer Inc. $PFE Position Lifted by Fifth Third Bancorp

July 12 at 11:19 AM | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

PFE, NVAX, and JNJ Company Descriptions

Johnson & Johnson NYSE:JNJ

$257.82 +0.84 (+0.33%)

Closing price 07/13/2026 03:59 PM Eastern

Extended Trading

$258.11 +0.29 (+0.11%)

As of 07:08 AM Eastern

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Novavax NASDAQ:NVAX

$8.91 -0.42 (-4.50%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$9.01 +0.10 (+1.13%)

As of 07:07 AM Eastern

Novavax, Inc., a biotechnology company, that promotes improved health by discovering, developing, and commercializing vaccines to protect against serious infectious diseases. It offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. It focuses on urgent health challenges, which is evaluating vaccines for COVID-19, influenza, and COVID-19 influenza combination. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It is also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Pfizer NYSE:PFE

$24.46 +0.29 (+1.20%)

Closing price 07/13/2026 03:59 PM Eastern

Extended Trading

$24.50 +0.03 (+0.14%)

As of 07:08 AM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PFE, NVAX, and JNJ Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PFE, NVAX, and JNJ Earnings

Compare Dividends

Latest PFE, NVAX, and JNJ Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PFE, NVAX, and JNJ Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PFE, NVAX, and JNJ Company Descriptions

Johnson & Johnson NYSE:JNJ

Novavax NASDAQ:NVAX

Pfizer NYSE:PFE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest PFE, NVAX, and JNJ Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest PFE, NVAX, and JNJ Earnings

Compare Dividends

Latest PFE, NVAX, and JNJ Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

PFE, NVAX, and JNJ Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

PFE, NVAX, and JNJ Company Descriptions

Johnson & Johnson NYSE:JNJ

Novavax NASDAQ:NVAX

Pfizer NYSE:PFE

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools